A major clinical trial in The Lancet Psychiatry found that boosting dopamine with pramipexole improved symptoms in treatment-resistant depression. This challenges the long-dominant serotonin deficiency theory
Supporting those findings, another study showed that agomelatine, a serotonin-blocking drug, consistently reduced anxiety …
The post Revisiting Depression — Dopamine-Serotonin Balance Gains Attention for Treatment-Resistant Depression appeared first on Global Research.